Genomic Health, Inc. (NQ: GHDX)
26.46 USD  -0.30 (-1.12%)
Official Closing Price  /  Updated: 8:10 PM EDT, Apr 24, 2014  /  Add to My Watchlist      
(GHDX) Community Analysis from
April 25, 2014
(Stock Blog Hub, 10/23/12)
Consistent uptrend in Oncotype sales, pipeline development, strategic investments and impressive second quarter performance have helped Genomic Health (GHDX), a global cancer company, to...(read more)
(Stock Blog Hub, 12/1/11)
Genomic Health (GHDX), an oncology based biotech company, will present results from 16 studies at the San Antonio Breast Cancer Symposium in December. The company has been recording...(read more)
(Stock Blog Hub, 7/23/10)
Genomic Health's (GHDX) first quarter 2010 loss of $0.07 per share missed the Zacks Consensus Estimate of a loss of $0.03. Although the company's lead product, Oncotype DX breast...(read more)
Genomic Health (GHDX) Company Overview

There is no analysis for GHDX yet. But you can go to Wikinvest to help create one!


Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here